mylotarg - gemtuzumab ozogamicin injection, powder, lyophilized, for solution
(Gemtuzumab Ozogamicin)Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.
Usage: Mylotarg treats newly-diagnosed CD33-positive acute myeloid leukemia (AML) in adults and pediatric patients 1 month and older, and relapsed or refractory CD33-positive AML in adults and pediatric patients 2 years and older.